Top

Published in:

01-02-2014 | Editorial

Chronic kidney disease and the aging population

Authors: Marcello Tonelli, Miguel Riella

Published in: Journal of Nephrology | Issue 1/2014

Excerpt

Youth, which is forgiven everything, forgives itself nothing: age, which forgives itself everything, is forgiven nothing.

-George Bernard Shaw

…

Available only for authorised users

World Health Organization (2012) Good health adds life to years: global brief for World Health Day 2012. Geneva

Wiener JM, Tilly J (2002) Population aging in the United States of America: implications for public programmes. Int J Epidemiol 31:776–781PubMedCrossRef

Couser WG, Remuzzi G, Mendis S et al (2011) The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80:1258–1270PubMedCrossRef

Select Committee on Public Service and Demographic Change (2013) Ready for aging?. Report House of Lords, London

Davies DF, Shock NW (1950) Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29:496–507PubMedCentralPubMedCrossRef

Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822PubMedCrossRef

Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047PubMedCrossRef

Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8:117PubMedCentralPubMedCrossRef

Arora P, Vasa P, Brenner D et al (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185:E417–E423PubMedCentralPubMedCrossRef

10.

James MT, Hemmelgarn BR, Tonelli M (2010) Early recognition and prevention of chronic kidney disease. Lancet 375:1296–1309PubMedCrossRef

11.

Kurella M, Covinsky KE, Collins AJ et al (2007) Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146:177–183PubMedCrossRef

12.

Hemmelgarn BR, James MT, Manns BJ et al (2012) Rates of treated and untreated kidney failure in older vs younger adults. JAMA 307:2507–2515PubMedCrossRef

13.

Keith DS, Nichols GA, Gullion CM et al (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663PubMedCrossRef

14.

Hemmelgarn BR, Manns BJ, Lloyd A et al (2010) Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303:423–429PubMedCrossRef

15.

O’Hare AM, Bertenthal D, Covinsky KE et al (2006) Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 17:846–853PubMedCrossRef

16.

Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830PubMedCrossRef

17.

Thorsteinsdottir B, Montori VM, Prokop LJ et al (2013) Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients. Clin Interv Aging 8:797–807PubMedCentralPubMedCrossRef

18.

Chandna SM, Da Silva-Gane M, Marshall C et al (2011) Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 26:1608–1614PubMedCrossRef

19.

Murtagh FE, Marsh JE, Donohoe P et al (2007) Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 22:1955–1962PubMedCrossRef

20.

Kurella Tamura M, Covinsky KE, Chertow GM et al (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539–1547PubMedCrossRef

21.

Lamping DL, Constantinovici N, Roderick P et al (2000) Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 356:1543–1550PubMedCrossRef

22.

Unruh ML, Newman AB, Larive B et al (2008) The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc 56:1608–1617PubMedCrossRef

23.

Knoll GA (2013) Kidney transplantation in the older adult. Am J Kidney Dis 61:790–797PubMedCrossRef

24.

Merion RM, Ashby VB, Wolfe RA et al (2005) Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 294:2726–2733PubMedCrossRef

25.

Cohen B, Smits JM, Haase B et al (2005) Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant 20:34–41PubMedCrossRef

26.

Gill J, Bunnapradist S, Danovitch GM et al (2008) Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis 52:541–552PubMedCrossRef

27.

Gill JS, Tonelli M, Johnson N et al (2005) The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int 68:2345–2351PubMedCrossRef

28.

O’Hare AM, Kaufman JS, Covinsky KE et al (2009) Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Intern Med 150:717–724PubMedCrossRef

29.

Mohanlal V, Weir M (2011) Kidney transplantation in the elderly: it’s not all gloom and doom. ASN Kidney News 3:15–17

Title: Chronic kidney disease and the aging population
Authors: Marcello Tonelli
Miguel Riella
Publication date: 01-02-2014
Publisher: Springer International Publishing
Published in: Journal of Nephrology / Issue 1/2014
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-014-0038-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2014

The management of hyponatremia in HIV disease

Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension

Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy

Drug-eluting stent or coronary artery bypass graft surgery in hemodialysis patients?

The association of ECG and echocardiographic abnormalities with sudden cardiac death in a dialysis patient cohort

Propensity-matched comparison of drug-eluting stent implantation and coronary artery bypass graft surgery in chronic hemodialysis patients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials